top of page

VieCure and Cencora Collaborate to Offer the VieCure™ A.I. enabled Clinical Decision Support Platform and EMR to Oncology Physician Practices

The VieCure™ platform is the first Platinum Trusted Solution in Cencora’s new Trusted Vendor Program


DENVER, Colorado, October 16, 2020 - Today, VieCure announced a strategic collaboration with Cencora, part of AmerisourceBergen, to offer their next generation oncology A.I. enabled CDS solution and smart EMR to certain ION member oncology physician practices. VieCure is a cloud-based platform that is designed to help oncologists more fully embrace the world of next generation tumor sequencing, biomarker testing, targeted treatment, combination approaches and neo-adjuvant care. The VieCure platform is the first A.I. enabled solution to integrate the EMR with the precision oncology infrastructure necessary to assist oncologists in making evidence-based, payer aligned decisions for patients. Oncologists can compare patient data against the latest clinical evidence, clinical trials and clinical treatment guidelines or plans which can then become actionable via the embedded VieCure EMR. "We are very proud to partner with Cencora and their Trusted Vendor Program to help bring next-generation tools to the oncologists that are managing an ever-increasing amount of data and knowledge. The VieCure platform will enable practices to improve their usage of precision oncology by providing them with the tools and guidance to provide this high-quality care to their patients," said Dr. Fred Ashbury, Chief Scientific Officer at VieCure, "The high-quality data that is produced by properly using the platform can be used to drive practices in real-time with dashboards and reporting for research, benchmarking and value-based care programs. Equipping practices and providers with these data and tools, in real-time, will only increase their knowledge to provide optimal, personalized care and additional insights to efficiently manage their practices." Cencora's Trusted Vendor Program is composed of a select group of vendors that meet a rigorous set of criteria and standards and is offered to certain Cencora member oncology practices as a way for them to select vendors to assist them in managing the needs of their practices and patients.


The VieCure platform includes:


  • SOCRATES - A.I. enabled clinical inference engine

  • PLATO - codified clinical content library with thousands of clinical rules and treatment plans which meet or exceed the latest in clinical evidence

  • ARISTOTLE - 'smart' EMR (comprehensive including medical oncology, radiation oncology, surgical oncology, palliative care in oncology and survivorship)

  • AESARA - remote patient monitoring / smart patient app (Android/iOS)

  • EUCLID - integrated tele-oncology

  • ZENO - integrated data / analytics platform


"VieCure will provide those Cencora member oncology practices that choose to use it with information designed to offer improved insights that may be useful during the member physician's clinical decision-making process. Additionally, we are integrating VieCure with our inventory management cabinets and codifying our clinical content to ensure access to key information and compliance with our new evidence-driven contracts," said Susan Weidner, Senior Vice President, IntrinsiQ Specialty Solutions, a part of AmerisourceBergen. ​ The VieCure platform is hosted via the Microsoft Azure Cloud allowing for simple scalability and seamless upgrades and is offered on a Software as a Service Model, in an effort to eliminate maintenance, hosting and upgrade fees, as much as possible. The VieCure platform is now operating in practices within the United States and in the Caribbean.


About Cencora


Cencora is the largest physician service organization and GPO specializing in the support of community oncology. Cencora provides GPO procurement services, technologies, advocacy resources and expertise to more than half of the community-based oncology practices in the nation to help improve their clinical and operational management. For more information, go to www.iononline.com.


About VieCure


VieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and smart electronic medical record in oncology. The VieCure™ platform is a real-time decision support system that combines clinical knowledge with patient data to assist oncologists and hematologists in generating personalized treatment plans and managing a patient's treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. For more information, please visit www.viecure.com and connect with VieCure on LinkedIn, Facebook, and Twitter. ​ For media inquiries, please contact Michael Power at michael.power@viecure.com.

bottom of page